Preclinical Assessment of Atorvastatin for Treatment of Endocardial Fibroelastosis
Open Access
- 30 July 2025
- journal article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 10 (9) , 101282
Abstract
No abstract availableKeywords
Funding Information
- Additional Ventures LLC
- German Research Foundation
This publication has 41 references indexed in Scilit:
- Development of a UPLC–MS/MS method for the simultaneous determination of atorvastatin, 2‐hydroxy atorvastatin, and naringenin in rat plasma and its application to pharmacokinetic interaction studiesBiomedical Chromatography, 2022
- Endothelial-to-Mesenchymal Transition as Underlying Mechanism for the Formation of Double-Chambered Right VentriclePediatric Cardiology, 2022
- Perinatal Outcomes After Statin Exposure During PregnancyJAMA Network Open, 2021
- Flow disturbances and progression of endocardial fibroelastosis — a case reportCardiovascular Pathology, 2019
- The Role of the Transcription Factor KLF2 in Vascular Development and Disease2014
- Inflammation-Induced Endothelial-to-Mesenchymal TransitionThe American Journal of Pathology, 2011
- Assessment of Left Ventricular Endocardial Fibroelastosis in Fetuses With Aortic Stenosis and Evolving Hypoplastic Left Heart SyndromeThe American Journal of Cardiology, 2010
- Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilizationCardiovascular Research, 2006
- Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statinsAmerican Journal of Medical Genetics Part A, 2004
- Techniques for perfusion and storage of heterotopic heart transplants in miceMicrosurgery, 1985